slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 75,331-75,360
Pages 3,225
Rows per page 30
Component
75,331-75,360 of 96,741
186
The slide uses direct quotes to undermine the credibility of the CEO's projections.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
187
Uses a quote from a VW employee to validate the argument.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
188
Uses a quote from a VW employee to undermine the company's timeline.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
02
Soleno Therapeutics (SLNO)Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
03
The slide uses anonymous expert testimony to undermine the company's clinical trial integrity and market prospects.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
04
The slide uses a direct user testimonial to highlight product safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
06
The slide uses a social media post as a testimonial to highlight negative patient outcomes.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
07
The slide uses a screenshot of a Facebook post to undermine the clinical trial results of the drug VYKAT.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
11
The slide uses inflammatory language ('smelled a rat', 'drop like flies') to frame the company and investigator as negligent.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
12
Uses social media screenshots as primary evidence to build a case against the drug's safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
13
Uses anecdotal evidence from Facebook groups to build a case for systemic safety issues.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
14
The slide uses a specific social media post as a case study to infer broader safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
15
Uses a screenshot of a Facebook group post as primary evidence to support the claim of medical danger.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
17
The slide highlights a discrepancy between the FDA label's explicit warnings about DKA and the company's omission of this risk in their phase 3 and open-label manuscripts.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
20
The slide uses direct excerpts from a medical paper to build a case against the drug's safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
21
The slide uses a direct quote from the Pediatric Endocrine Society guidelines to expose the company's failure to address known side effects in their trial design.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
22
The slide uses a direct quote from a medical paper to expose the ineffectiveness of the company's recommended treatment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
23
The slide uses direct quotes from a KOL to build a case against the safety of a drug (Vykat) in the context of PWS.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
24
The slide uses a combination of medical argumentation and cited conclusions to build a case against a specific treatment protocol.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
26
The slide uses anecdotal evidence from online discussion groups to highlight patient safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
27
The slide uses screenshots of Facebook group discussions to provide anecdotal evidence of adverse drug reactions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
28
The slide uses screenshots of Facebook group posts as primary evidence of adverse drug reactions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
01
This is a regulatory filing document (Citizen Petition) formatted as a letter.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Attention1 hit
02
This is a text-heavy regulatory filing document, likely part of a petition to the FDA regarding safety concerns.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Problem & Complication1 hit
03
This appears to be a page from a regulatory filing or activist short report, focusing on adverse event reporting and potential obfuscation by the manufacturer.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Problem & Complication1 hit
04
This slide functions as a legal/regulatory petition argument, using evidence-based reasoning to refute the adequacy of current safety warnings.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Problem & Complication1 hit
06
This appears to be a page from an activist short report or regulatory challenge document.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Desire1 hit
07
This slide functions as a legal/regulatory petition document, outlining specific grievances regarding trial design, data integrity, and patient safety.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Solution & Approach1 hit
08
This is a text-heavy regulatory document page.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Solution & Approach1 hit
09
Standard legal certification language.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller 1 hit